Levonorgestrel implant [75 mg subdermal implant] for contraception
Cycle 2 | DrugsHTA Council Recommendation (as of 26 November 2024)
The HTA Council positively recommends the inclusion of levonorgestrel implant [75 mg subdermal implant] for contraception in the PNF and thus the government financing of the said health technology.
Relevant Information
- Status: With Final HTA Council Recommendation with SOH Decision
- Topic Assignment: Internal Assessment
- Policy Question: Should levonorgestrel implant [75 mg subdermal implant] for contraception for the treatment of human immunodeficiency virus (HIV) infection in pediatric population be included in the Philippine National Formulary (PNF)?
Evidence and Relevant Documents